BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37309112)

  • 1. Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients.
    Choi W; Kim YH; Woo SM; Yu Y; Lee MR; Lee WJ; Chun JW; Sim SH; Chae H; Shim H; Lee KS; Kong SY
    Cancer Res Treat; 2023 Oct; 55(4):1077-1086. PubMed ID: 37309112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform.
    Pan B; Zhao D; Liu Y; Li N; Song C; Li N; Li X; Zhao Z
    In Vitro Cell Dev Biol Anim; 2021 May; 57(5):510-518. PubMed ID: 33950403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of patient-derived organoids for guiding personalized therapies in breast cancer patients.
    Wu H; Wang W; Zhang Y; Chen Y; Shan C; Li J; Jia Y; Li C; Du C; Cai Y; Zhang Y; Zhang S; Wu F
    Int J Cancer; 2024 Jul; 155(2):324-338. PubMed ID: 38533706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma.
    Chen H; Gotimer K; De Souza C; Tepper CG; Karnezis AN; Leiserowitz GS; Chien J; Smith LH
    Gynecol Oncol; 2020 Jun; 157(3):783-792. PubMed ID: 32253045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of patient-derived tumor organoids generation from malignant effusions.
    Seghers S; Le Compte M; Hendriks JMH; Van Schil P; Janssens A; Wener R; Komen N; Prenen H; Deben C
    Crit Rev Oncol Hematol; 2024 Mar; 195():104285. PubMed ID: 38311013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-Generation Preclinical Functional Testing Models in Cancer Precision Medicine: CTC-Derived Organoids.
    Huang L; Xu Y; Wang N; Yi K; Xi X; Si H; Zhang Q; Xiang M; Rong Y; Yuan Y; Wang F
    Small Methods; 2024 Jan; 8(1):e2301009. PubMed ID: 37882328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screening.
    Li J; Xu H; Zhang L; Song L; Feng D; Peng X; Wu M; Zou Y; Wang B; Zhan L; Hua G; Zhan X
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2637-2647. PubMed ID: 31598791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response.
    Frappart PO; Walter K; Gout J; Beutel AK; Morawe M; Arnold F; Breunig M; Barth TF; Marienfeld R; Schulte L; Ettrich T; Hackert T; Svinarenko M; Rösler R; Wiese S; Wiese H; Perkhofer L; Müller M; Lechel A; Sainz B; Hermann PC; Seufferlein T; Kleger A
    United European Gastroenterol J; 2020 Jun; 8(5):594-606. PubMed ID: 32213029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful creation of pancreatic cancer organoids by means of EUS-guided fine-needle biopsy sampling for personalized cancer treatment.
    Tiriac H; Bucobo JC; Tzimas D; Grewel S; Lacomb JF; Rowehl LM; Nagula S; Wu M; Kim J; Sasson A; Vignesh S; Martello L; Munoz-Sagastibelza M; Somma J; Tuveson DA; Li E; Buscaglia JM
    Gastrointest Endosc; 2018 Jun; 87(6):1474-1480. PubMed ID: 29325707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of organoids from a patient with adenomyoepithelioma of the breast.
    Luo X; She J; Xu T; Zhou Y; Xu C; Jiang J; Li T; Liu H; Shen H; Yin B; Dai B
    Bioengineered; 2021 Dec; 12(2):11578-11585. PubMed ID: 34874791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
    Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
    Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of factors influencing the success rate of organoid culture in 1231 cases of colorectal cancer].
    Zeng YL; Wang SD; Li YR; Xue WS; Wang T; Tang YT; Zheng H; Chen ZX; Lan JQ; Yan J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Aug; 26(8):780-786. PubMed ID: 37574295
    [No Abstract]   [Full Text] [Related]  

  • 14. Establishment of Patient-Derived Gastric Cancer Organoid Model From Tissue Obtained by Endoscopic Biopsies.
    Song H; Park JY; Kim JH; Shin TS; Hong SA; Huda MN; Kim BJ; Kim JG
    J Korean Med Sci; 2022 Jul; 37(28):e220. PubMed ID: 35851862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advantages and limitations of 3D organoids and ex vivo tumor tissue culture in personalized medicine for prostate cancer.
    Mickova A; Morong M; Levková M; Kurfúrstová D; Kharaishvili G; Überall I; Student V; Student V; Drapela S; Soucek K; Bouchal J
    Klin Onkol; 2022; 35(6):473-481. PubMed ID: 36513514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making.
    Chitrangi S; Vaity P; Jamdar A; Bhatt S
    BMC Cancer; 2023 Jul; 23(1):689. PubMed ID: 37479967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of an organoid bank of biliary tract and pancreatic cancers and its application for personalized therapy and future treatment.
    Saito Y
    J Gastroenterol Hepatol; 2019 Nov; 34(11):1906-1910. PubMed ID: 31264257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsies.
    Lee JH; Kim H; Lee SH; Ku JL; Chun JW; Seo HY; Kim SC; Paik WH; Ryu JK; Lee SK; Lowy AM; Kim YT
    Gut Liver; 2022 Jul; 16(4):625-636. PubMed ID: 34916338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
    Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
    Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing Cancer Therapy Predictions with Patient-Derived Organoid Models of Metastatic Breast Cancer.
    Önder CE; Ziegler TJ; Becker R; Brucker SY; Hartkopf AD; Engler T; Koch A
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.